Real-world evidence (RWE): asthma clinical-outcomes, fluticasone furoate/vilanterol (FF/VI) versus (vs) beclometasone dipropionate/formoterol (BDP/FOR) - Amsterdam 2025

Appraising and defining clinical practice: asthma and COPD

Chair(s): Alexandru Corlateanu, Wang Chun Kwok

Session type: Poster session

Real-world evidence (RWE): asthma clinical-outcomes, fluticasone furoate/vilanterol (FF/VI) versus (vs) beclometasone dipropionate/formoterol (BDP/FOR)

Ashley Woodcock

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Overreliance on oral corticosteroids (OCS) in European asthma management: EU-LAMA survey.

Tomasz Debowski

Poster

Abstract

Real-world evidence (RWE): asthma clinical-outcomes, fluticasone furoate/vilanterol (FF/VI) versus (vs) beclometasone dipropionate/formoterol (BDP/FOR)

Ashley Woodcock

Poster

Abstract

Insufficient treatment optimisation in COPD patients following clinical worsening in an electronic medical record database

Nicolas Roche

Poster

Abstract

Impact of national clinical guidelines versus RCT criteria on biologic eligibility in asthma

Dominic Marshall

Poster

Abstract

Oral corticosteroids in asthma what are patients perceptions and experiences?

Liam Petrie

Poster

Abstract

Asthma control in Germany: Results of a real-life survey

Roland Buhl

Poster

Abstract

Accelerating access to asthma biologics in Wales

Michael Pynn

Poster

Abstract

Cost-effectiveness of new asthma treatment guidelines in community

Devon Ward

Poster

Abstract

Current practices and future directions in COPD management in the Republic of Ireland

Jayleigh Lim

Poster

Abstract

German expert survey: on the practical relevance of the GOLD report - DELFIN2

Jutta Beier

Poster

Abstract

GINA step 4 and 5 single inhaler triple therapy (SITT) management in European asthma patients: EU-LAMA survey.

Tomasz Debowski

Poster

Abstract

Concomitant SABA prescription on top of ICS/LABA in the NEWTON study

Fulvio Braido

Poster

Abstract

Biologic therapy trends in severe asthma: BREATHE study

Iñigo Ojanguren Arranz

Poster

Abstract

Improving patient outcomes in severe asthma: utilising a hub and spoke model to expand care delivery

Adel Mansur

Abstract

Brown inhaler vs blue inhaler behaviours and their relevance to guidelines-based asthma care

Lynn Elsey

Poster

Abstract

Physicians adjust single inhaler triple therapy (SITT) asthma treatment according to individual patient's conditions: EU LAMA survey

Tomasz Debowski

Poster

Abstract

Physicians know which patients with asthma benefit most from single inhaler triple therapy (SITT): EU-LAMA survey

Michal Gabriel Panek

Abstract

Regional variations and trends in the use of maintenance inhaled medications in chronic obstructive pulmonary disease

Jeenat Mehareen

Poster

Abstract

A time-clocked care pathway on severe asthma: A global consensus by Delphi methodology

Mohit Bhutani

Poster

Abstract

COPD disease burden: evidence from an Italian nationwide survey.

Dejan Radovanovic

Poster

Abstract

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}